M L Berman

2.5k total citations
39 papers, 2.0k citations indexed

About

M L Berman is a scholar working on Oncology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, M L Berman has authored 39 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Obstetrics and Gynecology and 7 papers in Reproductive Medicine. Recurrent topics in M L Berman's work include RNA and protein synthesis mechanisms (6 papers), Ovarian cancer diagnosis and treatment (5 papers) and Endometrial and Cervical Cancer Treatments (4 papers). M L Berman is often cited by papers focused on RNA and protein synthesis mechanisms (6 papers), Ovarian cancer diagnosis and treatment (5 papers) and Endometrial and Cervical Cancer Treatments (4 papers). M L Berman collaborates with scholars based in United States, Italy and France. M L Berman's co-authors include William P. Sisk, J A Blessing, Howard D. Homesley, L.B. Twiggs, Rodrigue Mortel, R J Barrett, Philip J. DiSaia, Luis Vaccarello, Blaire Anderson and Daniel L. Clarke‐Pearson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

M L Berman

39 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M L Berman United States 22 636 541 466 437 414 39 2.0k
Masaki Inoue Japan 27 934 1.5× 503 0.9× 394 0.8× 515 1.2× 273 0.7× 91 2.4k
Yoshio Yoshida Japan 28 591 0.9× 318 0.6× 652 1.4× 824 1.9× 314 0.8× 185 2.6k
Ryuichi Kudo Japan 29 1.1k 1.7× 483 0.9× 962 2.1× 845 1.9× 220 0.5× 98 2.8k
Thomas Bauknecht Germany 27 846 1.3× 777 1.4× 213 0.5× 581 1.3× 270 0.7× 82 2.2k
Kiichiro Noda Japan 18 371 0.6× 409 0.8× 556 1.2× 721 1.6× 409 1.0× 75 1.5k
Michael Conner United States 23 489 0.8× 521 1.0× 448 1.0× 465 1.1× 222 0.5× 72 1.9k
Soon Beom Kang South Korea 23 498 0.8× 315 0.6× 520 1.1× 433 1.0× 380 0.9× 77 1.8k
A.P.M. Jongsma Netherlands 15 609 1.0× 451 0.8× 219 0.5× 507 1.2× 179 0.4× 27 1.5k
N. N. Teng United States 21 560 0.9× 300 0.6× 589 1.3× 537 1.2× 241 0.6× 37 2.1k
Patricia S. Braly United States 25 499 0.8× 483 0.9× 504 1.1× 987 2.3× 695 1.7× 66 2.4k

Countries citing papers authored by M L Berman

Since Specialization
Citations

This map shows the geographic impact of M L Berman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M L Berman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M L Berman more than expected).

Fields of papers citing papers by M L Berman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M L Berman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M L Berman. The network helps show where M L Berman may publish in the future.

Co-authorship network of co-authors of M L Berman

This figure shows the co-authorship network connecting the top 25 collaborators of M L Berman. A scholar is included among the top collaborators of M L Berman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M L Berman. M L Berman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chase, Dana M., et al.. (2006). Malignant eccrine spiradenoma of the vulva: a case report and review of the literature. International Journal of Gynecological Cancer. 16(3). 1465–1469. 18 indexed citations
2.
Chan, John K., Bradley J. Monk, Casey Brewer, et al.. (2003). HPV infection and number of lifetime sexual partners are strong predictors for ‘natural’ regression of CIN 2 and 3. British Journal of Cancer. 89(6). 1062–1066. 42 indexed citations
3.
Keefe, Kristen A., Michael J. Schell, Casey Brewer, et al.. (2001). A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia.. PubMed. 10(10). 1029–35. 41 indexed citations
4.
Omura, G, J A Blessing, Luis Vaccarello, et al.. (1997). Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.. Journal of Clinical Oncology. 15(1). 165–171. 208 indexed citations
5.
Sturgeon, Susan R., Louise A. Brinton, M L Berman, et al.. (1997). Intrauterine device use and endometrial cancer risk. International Journal of Epidemiology. 26(3). 496–500. 25 indexed citations
6.
Potischman, Nancy, R N Hoover, Louise A. Brinton, et al.. (1996). Case--Control Study of Endogenous Steroid Hormones and Endometrial Cancer. JNCI Journal of the National Cancer Institute. 88(16). 1127–1135. 210 indexed citations
7.
McGuire, William P., William J. Hoskins, Mark F. Brady, et al.. (1995). Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study.. Journal of Clinical Oncology. 13(7). 1589–1599. 149 indexed citations
8.
Granger, Gale A., C.G. Hwang, Philip J. DiSaia, et al.. (1994). Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancy. International Journal of Gynecology & Obstetrics. 45(2). 203–203. 1 indexed citations
9.
Lucci, Joseph A., Alberto Manetta, Federica Cappuccini, et al.. (1993). Immunotherapy of ovarian cancer. II. In vitro generation and characterization of lymphokine-activated killer T cells from the peripheral blood of recurrent ovarian cancer patients. International Journal of Gynecology & Obstetrics. 40(2). 179–180. 1 indexed citations
10.
Fridman, Rafael, Robert E. Bird, Matti Höyhtyä, et al.. (1993). Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme. Biochemical Journal. 289(2). 411–416. 74 indexed citations
11.
Kolb, Brigitte, Richard E. Buller, Joseph P. Connor, Philip J. DiSaia, & M L Berman. (1992). Effects of early postoperative chemotherapy on wound healing.. PubMed. 79(6). 988–92. 34 indexed citations
12.
Manetta, Alberto, et al.. (1990). In vitro cytotoxicity of human recombinant tumor necrosis factor α in association with radiotherapy in a human ovarian carcinoma cell line. Gynecologic Oncology. 38(2). 200–202. 7 indexed citations
13.
Sutton, Gregory P., John A. Blessing, Howard D. Homesley, M L Berman, & John H. Malfetano. (1989). Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.. Journal of Clinical Oncology. 7(11). 1672–1676. 94 indexed citations
14.
Tennant, Forest S. & M L Berman. (1988). Stepwise detoxification from cocaine. Postgraduate Medicine. 84(2). 225–235. 12 indexed citations
15.
Burd, Parris R., Gordon J. Freeman, Stephen D. Wilson, et al.. (1987). Cloning and characterization of a novel T cell activation gene.. The Journal of Immunology. 139(9). 3126–3131. 72 indexed citations
16.
Rettenmaier, Mark A., et al.. (1986). Semipermanent right atrial catheter in gynecologic cancer patients. International Journal of Gynecology & Obstetrics. 24(5). 386–387. 6 indexed citations
17.
Berman, M L, et al.. (1984). Selection of lac gene fusions in vivo: ompR-lacZ fusions that define a functional domain of the ompR gene product. Journal of Bacteriology. 159(2). 750–756. 41 indexed citations
18.
Weinstock, George M., M L Berman, Berge Hampar, et al.. (1983). Open reading frame expression vectors: a general method for antigen production in Escherichia coli using protein fusions to beta-galactosidase.. Proceedings of the National Academy of Sciences. 80(14). 4432–4436. 93 indexed citations
19.
Berman, M L & Arthur Landy. (1979). Promoter mutations in the transfer RNA gene tyrT of Escherichia coli.. Proceedings of the National Academy of Sciences. 76(9). 4303–4307. 47 indexed citations
20.
Ballon, Samuel C., et al.. (1978). Myeloblastoma (granulocytic sarcoma) of the ovary.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 102(9). 474–6. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026